This supposition is supported by the fact that (excluding hyper-mutated tumors) there are no occurrences of tumors with mutations in both RAD17 and either CHEK1, CHEK2 and WEE1 across all cancer types in TCGA. The gene discussed is CHEK2; the disease is cancer.